Myelofibrosis (Agnogenic Myeloid Metaplasia or AMM)

Myelofibrosis—also called agnogenic myeloid metaplasia (AMM), myelosclerosis, chronic idiopathic myelofibrosis, idiopathic myelofibrosis, myelosclerosis with myeloid metaplasia, and primary myelofibrosis—is a form of cancer that arises in the bone marrow.

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Before beginning treatment, ask your doctor about any clinical trials you should consider. Learn more about clinical trials for cancer patients.

Clinical trial eligibility flowcharts

Eligibility flowcharts map clinical trials to specific types of cancers to determine if a participant is eligible for the particular clinical trial. View all hematology eligibility flowcharts at the Stanford Cancer Institute.

Our Clinic

HEMATOLOGY PROGRAM

Receive expert care at a location convenient for you. Make an appointment at our clinic.